TGFβ1/Smads信号转导通路的变化在原发性肝癌发病机制中的作用

孔丽; 姚树坤; 马英; 王容琦; 张玉果

TGFβ1/Smads信号转导通路的变化在原发性肝癌发病机制中的作用

基金项目:

河北省自然科学基金资助(303516)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2421
- HTML全文浏览量: 17
- PDF下载量: 864
- 被引次数: 0
出版历程
- 出版日期: 2007-04-20

Effect of alteration of TGFβ Ⅰ/Smads signaling pathway on pathogenesis of HCC

Research funding:

摘要

摘要: 探讨TGFβ1/Smads信号转导通路的改变在原发性肝癌发病机制中的作用。应用western blotting法和RT-PCR法对肝癌组织TGFβ受体Ⅰ、TGFβ受体Ⅱ、Smad2,Smad4,Smad7蛋白和mRNA水平进行检测,并与正常肝组织和癌旁组织比较。结果显示肝癌组织TGFβRⅡ、Smad4 mRNA和蛋白表达较正常及癌旁组织显著降低,Smad7 mRNA和蛋白表达、Smad7/Smad4比值显著升高。提示TGFβ1/smads信号转导通路被抑制,使TGFβ1介导的抗增殖信号不能正常下传,可能是肝癌发生的机制之一。
- 原发性肝癌 /
- 肝组织 /
- TGFβ受体 /
- smads /
- TGFβ1/Smads信号通路
Abstract: To explore the effect of alteration of TGFβ Ⅰ/Smads signaling pathway on pathogenesis of HCC.The expression in protein level and mRNA level of TGFβ Ⅰ, TGFβⅡ, Smad2, Smad4 and Smad7 in HCC liver tissues were detected by western blotting asssays and RT-PCR assays, and compared with normal liver control tissue and adjacent nonneoplastic tissues.The expression of TGFβⅡ and Smad4 mRNA in HCC liver tissues were significantly lower than that in normal control liver and adjacent nonneoplastic tissues.The expression of Smad7 mRNA and the ratio of Smad7/Smad4 in HCC liver were significantly higher than that in normal control liver and adjacent nonneoplastic liver tissues.The tendency of protein expression of TGFβⅡ, Smad4 and Smad7 were similar to mRNA expression in HCC liver tissues.If the TGFβⅠ/Smads signaling pathway was repressed, the information of growth inhibition could not be transmitted.It might be one of the factors of HCC pathogenesis.
- hepatocellular carcinoma /
- liver tissue /
- TGFβ receptor Ⅰ /
- Smads /
- TGF βⅠ/Smads signaling pathway

HTML全文

参考文献(8)

[1]Kawabata M, Imamura T, Inoue H, et al.Intracellular signaling ofthe TGF-βsuperfamily by Smad proteins[J].Ann N Y Acad Sci, 1999, 886∶73-82.

[2]Hannon GJ, Beach D.P151NK4B is a potential effector of TGF-beta-induced cell cycle arrest[J].Nature, 1994, 371 (6494) ∶257-261.

[3]Villanueva A, Garcia C, Paules AB, et al.Disruption on the anti-proliferative TGF-beta signaling pathway in human pancreatic canc-er cells[J].On cogene, 1998, 17 (15) ∶1969-1978.

[4]Xu J, Attisano L.Mutations in the tumor suppressor Smad2 andSmad4 inactivate transforming growth factor beta signaling by targe-ting mads to the ubiquin proteasome pathway[J].Proc Natl Acad SciUSA, 2000, 97 (9) ∶4820-4825.

[5]Torbenson M, Marinopoulos S, Dang DT, et al.Smad4 overexpres-sion in hepatocellular carcinoma is strongly associated with transfor-ming growth factor betaⅡreceptor immunolabling[J].Hum Pathol, 2002, 33 (9) ∶871-876.

[6]Pran KD, Hardd L M.STRAP and Smad7 synergize in the inhibitionof transforming growth factorβsignaling[J].Molecular and cellularbiology, 1997, 20 (9) ∶3157-3167.

[7]Kleeff J, Ishiwata T, Maruyama H, et al.The TGFβsignaling inhib-itor Smad7 enhances tumorigencity in pancreatic cancer[J].Onco-gene, 1999, 18∶5363-5372.

[8]刘政, 季国忠, 缪林, 等.人肝癌及癌旁组织中Smad4、Smad7mRNA和蛋白表达研究[J].天津医药, 2004, 32 (12) ∶721-723.

施引文献

资源附件(0)

访问统计